Professor; Division Chief, Neurocritical Care
Duke University Medical Center, North Carolina
Cherylee W. J. Chang, MD, FCCM, FACP, FNCS; Division Chief, Neurocritical Care; Professor of Neurology, Duke University
Dr. Chang received her bachelor’s degree in Biological Sciences with Honors and Distinction from Stanford University and her medical degree at the University of California, San Diego. She completed residencies in neurology and internal medicine at Stanford University Medical Center and UC San Diego, respectively, and joint fellowships in critical care medicine and neurocritical care at the University of Virginia. She is board certified in neurology, critical care medicine, and neurocritical care.
She was the Medical Director of the Neuroscience Institute and Neurocritical Care at The Queen’s Medical Center (QMC) in Honolulu, Hawaii since 1999 and founded and directed QMC’s TJC-certified Primary and Comprehensive Stroke Center from 1997 until 2017. She relocated to Durham, North Carolina in 2020 to become the first Division Chief of Neurocritical Care at Duke University as a Professor of Neurology.
Dr. Chang is a member of the SCCM Council in the designated seat for the Neurosciences. She is a member of the American Board of Internal Medicine’s Critical Care Medicine Board Exam Committee, the American Board of Psychiatry and Neurology's Neurocritical Care Board Exam and was the third president of the Neurocritical Care Society from 2007 to 2009. She served in a leadership role in creating certification of individuals and accreditation of fellowship training programs in neurological critical care through her work with the United Council of Neurological Specialties as the chair of the Neurointensive Care Examination Committee. Dr. Chang is an Associate Editor of SCCM's journal, Critical Care Medicine. She is also a member of the Board of Directors of the Rehabilitation Hospital of the Pacific and is a founding member of the taskforce for Providers for Life-Sustaining Treatment (POLST) for the State of Hawaii.
Tuesday, January 24, 2023
10:45 AM – 11:45 AM PT
Disclosure(s): No relevant financial relationship(s) to disclose.